Contact this trialFirst, we need to learn more about you.
Immunotherapy
Pozelimab + Cemdisiran for Macular Degeneration
Recruiting1 awardPhase 3
Lakewood, Colorado
"This trial is testing two new drugs, pozelimab and cemdisiran, on patients with geographic atrophy caused by age-related macular degeneration. The goal is to see if these
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service